Life ScienceCompany
Telix Pharmaceuticals M&A Summary
Telix Pharmaceuticals has acquired 7 companies, including 6 in the last 5 years.
Telix Pharmaceuticals’ largest acquisition to date was in 2024, when it acquired RLS for $230M. Telix Pharmaceuticals has acquired in 3 different US states, and 3 countries. The Company’s most targeted sectors include life science (86%) and renewable energy (15%).
Telix Pharmaceuticals Business Overview
Where is Telix Pharmaceuticals headquartered?
Telix Pharmaceuticals is headquartered in North Melbourne, Australia.
What sector is Telix Pharmaceuticals in?
Telix Pharmaceuticals is a life science company.
M&A Summary
-
M&A Total Activity7
- M&A Buy Activity7
- Total Sectors Invested 2
- Total Countries Invested 3
- M&A Buy/Sell Connections 3
Unlimited Searches
